Gene · 4296
Papers1,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of JNK3 signaling in acute ischemic stroke cerebroprotection: A systematic review. | Biomed Pharmacother | 2025 | 41237460 | PubTator, text mining | PubMed |
| Mixed lineage kinase 3 contributes to myocardial ischemia/reperfusion injury by regulating neutrophil activation. | Basic Res Cardiol | 2025 | 41217483 | PubTator, text mining | PubMed |
| CircHOMER1 in mediating porcine skeletal muscle development. | BMC Genomics | 2025 | 41013185 | PubTator, text mining | PubMed |
| Role of Ferroptosis on Lung Epithelial Cells in Disease Progression and Treatment: A Review. | Med Sci Monit | 2025 | 40988320 | PubTator, text mining | PubMed |
Exploring Potential Causality and Molecular Mechanisms between Heart Failure and Renal Failure: Insights from Mendelian Randomization Studies, the MIMIC-IV Database and the Gene Expression Omnibus Database. | J Vasc Res | 2025 | 40875767 | PubTator, text mining | PubMed |
| JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer. | J Exp Clin Cancer Res | 2025 | 40826108 | PubTator, text mining | PubMed |
| Immunosuppressive MAP3K11 as an independent risk factor for progression-free survival promotes prostate cancer metastasis by regulating epithelial-mesenchymal transition. | Biochem Biophys Res Commun | 2025 | 40505551 | PubTator, text mining | PubMed |
| Mixed lineage kinase (MLK) controls tumor development and angiogenesis. | Angiogenesis | 2025 | 40314847 | PubTator, text mining | PubMed |
| MDNN-DTA: a multimodal deep neural network for drug-target affinity prediction. | Front Genet | 2025 | 40182923 | PubTator, text mining | PubMed |
| Bipartite binding of the intrinsically disordered scaffold protein JIP1 to the kinase JNK1. | Proc Natl Acad Sci U S A | 2025 | 39999166 | PubTator, text mining | PubMed |
| Prognostic Significance of CDK1 in Ovarian and Cervical Cancers. | J Cancer | 2025 | 39991589 | PubTator, text mining | PubMed |
| Exploring MAP3K genes in gastric cancer: biomarkers, tumor microenvironment dynamics, and chemotherapy resistance. | Hereditas | 2025 | 39901302 | PubTator, text mining | PubMed |
| Trillin inhibits MAP3K11/NF-κB/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancer. | iScience | 2025 | 39898047 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biochemical Evaluation of Novel MLK3 Inhibitors: A Target Hopping Example. | J Med Chem | 2025 | 39681301 | PubTator, text mining | PubMed |
| Activation of mixed lineage kinase 3 by fine particulate matter induces skin inflammation in human keratinocytes. | Toxicol Lett | 2024 | 39547318 | PubTator, text mining | PubMed |
| Marine Staurosporine Analogues: Activity and Target Identification in Triple-Negative Breast Cancer. | Mar Drugs | 2024 | 39452867 | PubTator, text mining | PubMed |
| Interpretable Fine-Grained Phenotypes of Subcellular Dynamics via Unsupervised Deep Learning. | Adv Sci (Weinh) | 2024 | 39239705 | PubTator, text mining | PubMed |
| Protease activated receptor-1 regulates mixed lineage kinase-3 to drive triple-negative breast cancer tumorigenesis. | Cancer Lett | 2024 | 39222677 | PubTator, text mining | PubMed |
| Infectious Diseases. | Adv Neurobiol | 2024 | 39207706 | PubTator, text mining | PubMed |
| Selective Degradation of MLK3 by a Novel CEP1347-VHL-02 PROTAC Compound Limits the Oncogenic Potential of TNBC. | J Med Chem | 2024 | 39207123 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4296/papers?page=2